SETH LERNER to Receptor, Fibroblast Growth Factor, Type 3
This is a "connection" page, showing publications SETH LERNER has written about Receptor, Fibroblast Growth Factor, Type 3.
Connection Strength
0.882
-
Targeted therapies for metastatic bladder cancer. J Urol. 2015 Jan; 193(1):8-9.
Score: 0.474
-
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun. 2019 07 05; 10(1):2977.
Score: 0.164
-
SIU-ICUD consultation on bladder cancer: basic science. World J Urol. 2019 Jan; 37(1):15-29.
Score: 0.158
-
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. Future Oncol. 2022 Jul; 18(21):2599-2614.
Score: 0.050
-
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol. 2017 09; 72(3):354-365.
Score: 0.035